Paul Harney, vice president, leads all large and mid-size biopharmaceutical business development efforts for Quintiles Commercial North America.
A veteran of the healthcare and life sciences industry, Paul joined Quintiles in 2015 with the overarching goal to help customers achieve and sustain peak commercialization faster through better market access and channel strategies. Paul draws on his specific expertise in strategy, communications, operations and analytics at the brand, division and corporate levels to identify opportunities to increase product value. His extensive experience with retail and institutional products covers several therapy areas, such as diabetes, respiratory, anti-infectives, urology, vaccines and dermatology, which allows him to quickly leverage best practices and initiatives that enhance go-to-market strategies.
Prior to joining Quintiles, Paul held leadership roles at various consulting firms that engaged biopharmaceutical companies in nearly all functional areas, including sales, marketing, medical affairs, business development and supply chain. Paul graduated with a bachelor’s degree in chemistry from Trinity College in Hartford, Conn., and holds a doctorate in philosophy from State University of New York at Stony Brook.